rivaroxaban oral suspension — Medica
Coronary artery disease
Initial criteria
- Patient is age ≥ 18 years
- Patient is taking concomitant aspirin, at least 75 mg daily
- If rivaroxaban oral suspension is being requested, patient is unable to have Xarelto tablets appropriately administered
Approval duration
1 year